Global Principal Clinical Scientist - Cardiorenal

Responsibilities:

• You will be responsible for scientific input to clinical development strategies and therapeutic areas.
• Provide scientific and clinical development input for the safe and efficient execution of assigned programs, ensuring the highest quality and full compliance of all outputs.
• Will contribute to the development of the scientific strategy of the clinical development plan, the design of trial related documents and the scientific oversight of clinical trials.
• You will facilitate a team to define and deliver the clinical strategy within programs.
• Define scientific strategy for multiple program components.
• You will lead the development of Clinical Development Program.
• Author clinical study documents and assists with development/critical review of submission documents.
• Contribute to authorship and review of manuscripts and conference abstracts.
• Collaboratively develop the clinical development strategy with project teams, providing input, guidance and mentorship for project teams.
• Contribute to the scientific analysis and interpretation of clinical data and the writing of clinical study reports, internal and external scientific meeting presentations and peer-reviewed publications, and all regulatory submission documents.
• Will foster close collaboration with other departments, defining and improving interfaces to other departments.

Qualifications:

• Bachelor's degree or equivalent in Science, Allied Health or Engineering.
• 8+ years experience in the biotechnology or pharmaceutical industry (or where relevant a biomedical research organization).
• 5+ years managing projects.
• In-depth knowledge in the drug development and manufacturing processes for pharmaceuticals (CMC, non-clinical, clinical, Regulatory Affairs).

The role is based in Glattbrugg, Switzerland and requires an onsite presence of 3 days per week.

About CSL Behring

CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.

CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.

To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit and CSL Plasma at .

Our Benefits